In this retrospective study of individuals with T2D, we identified a composite biomarker score derived from four circulating proteins—CXCL9, NfL, GDF15, and FGF21—which reflect distinct biological pathways, including inflammation, neuronal injury, stress signaling, and metabolic dysfunction. This evidence concerns the gene FGF21 and type 2 diabetes mellitus.